Swipe om te navigeren naar een ander artikel
Professor Emeritus, Utrecht University, Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
N.M. van Hemel Professor Emeritus, Utrecht University, Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
Remote monitoring of implanted cardiac devices is an evolving method for regular checks of their electronic integrity and functioning. The communication with the devices is carried out unsupervised with wireless trans-telephonic or cable-dependent linkage. The interrogation of the device examines several programmed functions and harvests the stored data of numerous events. The collected data constitute the base to decide whether the implanted device is operating properly and can give some information about the physical condition of the device recipient. Preliminary short-term results show favourable effects in terms of safety and cost and time saving as compared with the current face-to-face visits of conventional patient follow-ups. Remote monitoring of implanted devices will extend markedly in the coming years and its development touches many questions ranging from technical accuracy, patient benefit, cost-effectiveness and responsibilities of the provider and receivers of the delivered device data, to the role of the cardiologist and allied professionals and of course privacy rules. In this point of view, these questions are discussed in order to explore the consequences of device remote monitoring with nationwide Trials. (Neth Heart J 2009;17:434–7.)
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Elsner Ch. Review of published evidence-based applications of telemonitoring for the surveillance of cardiac rhythm management devices. Scientific Report, Graduate School of Management, Leipzig, Germany. 2008;1–16.
Germany R, Murray C. Use of device diagnostics in the outpatient management of heart failure. Am J Cardiol. 2007; 99: 6–11G.
Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol. 2007; 30(Suppl 1): S2–12.
Ricci RP, Morichelli L, Santini M. Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace. 2008; 10: 164–70.
Nielsen JC, Kottkamp H, Zabel M, et al. Automatic home monitoring of implantable cardioverter defibrillators. Europace. 2008; 10: 729–35.
Halimi F, Clementy J, Attuel P, Dessenne X, Amara W. Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace. 2008; 10: 1392–9.
Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace. 2008; 10: 707–25.
van Eck JW, van Hemel NM, de Voogt WG, et al. Routine followup after pacemaker implantation: frequency, pacemaker programming and professionals in charge. Europace. 2008; 10: 832–7.
Fauchier L, Sadoul N, Kouakam C, et al. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol. 2005; 28 (Suppl 1): S255–9.
Santini M, Ricci RP, Lunati M, et al. Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. J Interv Card Electrophysiol. 2009; 24: 53–61.
Chen J, Wilkoff BL, Choucair W, et al. Design of the Pacemaker REmote Follow-up Evaluation and Review (PREFER) trial to assess the clinical value of the remote pacemaker interrogation in the management of pacemaker patients. Trials. 2008; 9: 18.
Varma N. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Am Heart J. 2007; 154: 1029–34.
- Remote monitoring of implanted cardiac devices: a plea for a nationwide exploration
N. M. van Hemel
- Bohn Stafleu van Loghum